Compare NOW & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOW | SYK |
|---|---|---|
| Founded | 2004 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.2B | 141.2B |
| IPO Year | 2012 | N/A |
| Metric | NOW | SYK |
|---|---|---|
| Price | $154.70 | $355.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 31 | 15 |
| Target Price | $223.29 | ★ $431.57 |
| AVG Volume (30 Days) | ★ 9.0M | 1.6M |
| Earning Date | 01-28-2026 | 01-27-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | ★ 28.67 | N/A |
| EPS | 1.65 | ★ 7.61 |
| Revenue | $12,667,000,000.00 | ★ $24,381,000,000.00 |
| Revenue This Year | $21.62 | $12.01 |
| Revenue Next Year | $18.34 | $8.59 |
| P/E Ratio | $92.75 | ★ $46.39 |
| Revenue Growth | ★ 21.05 | 10.95 |
| 52 Week Low | $135.73 | $329.16 |
| 52 Week High | $239.62 | $406.19 |
| Indicator | NOW | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 7.98 | 44.45 |
| Support Level | $151.15 | $349.55 |
| Resistance Level | $809.66 | $359.81 |
| Average True Range (ATR) | 18.31 | 6.66 |
| MACD | -67.49 | -0.41 |
| Stochastic Oscillator | 0.41 | 32.75 |
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.